Alberta Investment Management Corp - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.

Quarter-by-quarter ownership
Alberta Investment Management Corp ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$342,261
-38.4%
17,606
-10.2%
0.00%
-40.0%
Q1 2023$555,995
-2.9%
19,5980.0%0.01%0.0%
Q4 2022$572,850
+5.9%
19,598
-4.2%
0.01%
+25.0%
Q3 2022$541,000
-23.0%
20,459
+29.3%
0.00%
-20.0%
Q2 2022$703,000
-10.2%
15,8270.0%0.01%
+25.0%
Q1 2022$783,000
+89.6%
15,827
+95.1%
0.00%
+33.3%
Q4 2021$413,000
+2.5%
8,113
-3.4%
0.00%
-40.0%
Q2 2020$403,000
-46.9%
8,400
-49.1%
0.01%
-61.5%
Q1 2020$759,000
-44.5%
16,500
-27.5%
0.01%
+8.3%
Q4 2019$1,367,000
-36.7%
22,750
-40.4%
0.01%
-40.0%
Q3 2019$2,161,000
+16.9%
38,200
+15.0%
0.02%
+17.6%
Q2 2019$1,849,000
+50.7%
33,211
+36.7%
0.02%
+54.5%
Q1 2019$1,227,000
+182.1%
24,300
+125.0%
0.01%
+120.0%
Q4 2018$435,000
-60.8%
10,800
-32.5%
0.01%
-44.4%
Q3 2018$1,109,000
-34.8%
16,000
-28.9%
0.01%
-40.0%
Q2 2018$1,702,000
+7.7%
22,500
-25.0%
0.02%0.0%
Q1 2018$1,581,000
-64.2%
30,000
-63.7%
0.02%
-61.5%
Q4 2017$4,418,000
+32.5%
82,700
+47.9%
0.04%
+25.8%
Q3 2017$3,334,00055,9000.03%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders